Small Molecule CDMO

Partnering with a CDMO for API drug substance services means putting your trust in their ability to handle your project’s needs, from sourcing materials to supporting regulatory applications. A strong small molecule CDMO should have deep expertise and experience backed by state-of-the-art facilities, comprehensive capabilities, and innovative processes that enable versatility and efficiency. This partnership also requires collaboration — choose a CDMO that works closely with your team, prioritizing effective communication and transparency at every step of the process.

Yes, SK pharmteco maintains the required knowledge, experience, and facilities necessary to safely handle the commercial-scale production of these compounds. We have a long history of successful production of highly potent APIs, including cytotoxic compounds, and maintain the specialized process development and analytical capabilities necessary to support this work.

CDMOs can provide valuable support and expertise to guide clients in navigating the complex and dynamic regulatory landscape to bring products successfully and efficiently to market. SK pharmteco maintains a strong culture of compliance, ensuring our production facilities are maintained in accordance with worldwide regulatory requirements for the CGMP production of drug substances. We guide partners in developing a regulatory strategy that aligns with their goals, taking phase-appropriate steps, and addressing any potential regulatory challenges. Our team will work closely with you to determine key validations for product development and can draft the necessary protocols and reports to support regulatory filings.